DAILY PROGRAM
Standard Time: GMT +09:00, Seoul/Tokyo
ROOM A
07:50-08:00
Opening
08:00-08:50
Plenary Session I
Young Tae Kim (Seoul National Univ.)
08:00-08:50
Cancer Evolution and How Early Intervention May Improve Chance of Cure
Nicholas McGranahan (Univ. College London, UK)
08:50-09:50
Session I (A) Journey to Make Personalized Medicine More Precise
Soon-Hee Jung (Yonsei Univ. Wonju)
08:50-09:10
Liquid Biopsy: A Role in Diagnosis and Management of Lung Cancer
Pimpin Incharoen (Mahidol Univ., Thailand)
09:10-09:30
Molecular Biomarker Testing for Non-Small Cell Lung Cancer: Consensus Statement of the Korean Cardiopulmonary Pathology Study Group
Sunhee Chang (Inje Univ.)
09:30-09:50
The Era of Personalized Medicine: How the Pathologist Can Make a Difference?
Philippe Joubert (Laval Univ., Canada)
09:50-10:10
Coffee Break
10:10-11:25
Session II (A) Oral Presentation I
Seung Joon Kim (The Catholic Univ. of Korea)
10:10-10:19
Development of Detection and Virtual Biopsy Model for Early-Lung Adenocarcinoma Using Diagnostic Chest Based on Machine Learning Algorithm
Juyoung Lee (Yonsei University)
10:19-10:28
Exosomal miR-1260b Derived from Non-Small Cell Lung Cancer Promotes Tumor Metastasis through the Inhibition of HIPK2
Dong Ha Kim (University of Ulsan)
10:28-10:37
Clinical Usefulness of Serum KL-6 Test for Predicting Occurrence and Assessing Severity of Treatment-Related Interstitial Lung Disease in Lung Cancer: A Single Center Cohort Study
Hwa-Kyung Park (Chonnam National University )
10:37-10:46
The Effects of Statin Use on Lung Cancer Development in Patients with Idiopathic Pulmonary Fibrosis Using Clinical Data Warehouse
Hye Seon Kang (The Catholic University of Korea)
10:46-10:55
Contribution of p53 in Sensitivity to EGFR Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer
Kyungtaek lm (University of Ulsan)
10:55-11:04
Spatial Cell Types Mapping from H&E-Stained Tumor Tissue Images via Deep Learning Trained by Spatial Transcriptomic Data of Lung Adenocarcinoma
Kwon Joong Na (Seoul National University)
11:04-11:13
Effectiveness of Cloud-Based Quality Control System Using Computer Program in a Korean National Lung Cancer Screening Program
Ji-Youn Song (National Cancer Center)
11:13-11:22
Clinical Utility of Plasma Cell-Free DNA EGFR Mutation Analysis in Patients with Treatment-Naïve Stage IV Non-Small Cell Lung Cancer
Bo-Guen Kim (Sungkyunkwan University)
11:25-12:10
Satellite Symposium I [ONO/BMS]
Dae Ho Lee (Univ. of Ulsan)
11:25-12:10
Recent Update of Checkmate 9LA and Checkmate 227, Pivotal Trials in 1L Non-Small Cell Lung Cancer
Manuel Cobo Dols (Hospital Regional Universitario Málaga, Spain)
12:10-13:00
Lunch Break
13:00-14:40
Session III (A) Moving Forward with Target Therapy
Jeong Seon Ryu (Inha Univ.)
13:00-13:25
Targeting mEGFR with 3rd Generation TKIs
Se-Woong Oh (Yuhan Corporation)
13:25-13:50
Cracking Open the Undruggable RAS:A Clinical Perspective
David S. Hong (MD Anderson Cancer Center, USA)
13:50-14:15
Targeting Fusion Driver Mutation
Alice Shaw (Novartis, USA)
14:15-14:40
Challenges in the Use of Targeted Therapy in Non-Small Cell Lung Cancer
Alex A. Adjei (Mayo Clinic, USA)
14:40-15:00
Coffee Break
15:00-16:40
Session IV (A) Advanced Surgical Techniques for Thoracic Malignancies
Hyun Koo Kim (Korea Univ.)
15:00-15:25
Subxiphoid Single Port VATS Thymectomy
Sukki Cho (Seoul National Univ.)
15:25-15:50
Robotic Thymectomy
Chang Hyun Kang (Seoul National Univ.)
15:50-16:15
Robotic Pulmonary Lobectomy
Giulia Veronesi (Humanitas Research Hospital, Italy)
16:15-16:40
Single Port Robotic Thoracic Surgery
Seong Yong Park (Yonsei Univ.)
16:40-16:50
Coffee Break
16:50-17:40
Satellite Symposium III [MSD]
Ji-Youn Han (National Cancer Center)
16:50-17:40
Role and Current Status of Immunotherapy in Lung Cancer
Mike Holmes (MSD, UK)
ROOM B
08:50-09:50
Session I (B) Updates in Lung Cancer Screening
Jin Mo Goo (Seoul National Univ.)
08:50-09:10
2-Year Experience of National Lung Cancer Screening in Korea
Yeol Kim (National Cancer Center)
09:10-09:30
Lung Cancer Screening with Low-Dose Computed Tomography for Non-Smokers
Pan-Chyr Yang (National Taiwan Univ., Taiwan)
09:30-09:50
Introduction of LEADER Project
Hee Joung Kim (Konkuk Univ.)
09:50-10:10
Coffee Break
10:10-11:25
Session II (B) Big Data and Registry
Choon-Taek Lee (Seoul National Univ.)
10:10-10:35
How to Develop Credible, Useful Real-World Evidence Including Artificial Intelligence and Big Data Analytics
Brian D. Bradbury (Amgen, USA)
10:35-11:00
Way of Real-World Evidence: Past, Present, and Future Opportunities in Korea
Ju-Young Shin (Sungkyunkwan Univ.)
11:00-11:15
Current Staging System and 9th Ed TNM: Perspective of Future TNM Classification
Hisao Asamura (Keio Univ., Japan)
11:15-11:25
Domestic Lung Cancer Disease Investigation Project
Ho Cheol Kim (Univ. of Ulsan)
11:25-12:10
Satellite Symposium II [Takeda]
Dong-Wan Kim (Seoul National Univ.)
11:25-12:10
New Standard of Care in the First-Line Anaplastic Lymphoma Kinase+Non-Small Cell Lung Cancer: Alunbrig ®
Michael Thomas (Universitätsklinikum Heidelberg, Germany)
12:10-13:00
Lunch Break
13:00-14:40
Session III (B) Korea-Japan Joint Symposium: Multidisciplinary Approach in Early and Locally Advanced Non-Small Cell Lung Cancer
Myung-Ju Ahn (Sungkyunkwan Univ.), Kentaro Tanaka (International committee of JLCS)
13:00-13:25
Updates of Radiation Therapy in Early Non-Small Cell Lung Cancer
Hitoshi Ishikawa (QST Hospital, Japan)
13:25-13:50
Neo-Adjuvant and Adjuvant Therapy Using Immune Checkpoint Inhibitors
Eun Joo Kang (Korea Univ.)
13:50-14:15
Neo-Adjuvant and Adjuvant Therapy Using Molecular Targeted Therapies
Masahiro Tsuboi (National Cancer Center Hospital East, Japan)
14:15-14:40
Promise and Pitfall in Early Efficacy Evaluation Using Pathologic Response and Minimal Residual Disease
Hyo Sup Shim (Yonsei Univ.)
14:40-15:00
Coffee Break
15:00-16:40
Session IV (B) Optimizing Radiation Therapy for Lung Cancer
Jin Hee Kim (Keimyung Univ.)
15:00-15:25
Optimal Strategy of Concurrent Chemoradiotherapy for Non-Small Cell Lung Cancer
Si Yeol Song (Univ. of Ulsan)
15:25-15:50
Optimal Dose Fractionation in Small Cell Lung Cancer (Limited Disease and Extensive Disease)
Sung Ho Moon (National Cancer Center)
15:50-16:15
Prophylactic Cranial Irradiation in Lung Cancer
Hideyuki Harada (Shizuoka Cancer Center, Japan)
16:15-16:40
Ultra-High Dose Rate Radiotherapy (FLASH)
Jin Sung Kim (Yonsei Univ.)